Photodynamic therapy with chlorin e(6) for skin metastases of melanoma

Photodynamic therapy (PDT) has been successfully applied in clinical settings to destroy neoplasms, but the efficacy of such a treatment is dependent on the type of neoplasm and the photosynthesizer used. Here, we perform a clinical assessment of PDT for skin metastases of pigmented melanoma using c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Photodermatology, photoimmunology & photomedicine photoimmunology & photomedicine, 2004-02, Vol.20 (1), p.21
Hauptverfasser: Sheleg, Sergey V, Zhavrid, Edvard A, Khodina, Tatsiana V, Kochubeev, Georgy A, Istomin, Yury P, Chalov, Vadim N, Zhuravkin, Ivan N
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 21
container_title Photodermatology, photoimmunology & photomedicine
container_volume 20
creator Sheleg, Sergey V
Zhavrid, Edvard A
Khodina, Tatsiana V
Kochubeev, Georgy A
Istomin, Yury P
Chalov, Vadim N
Zhuravkin, Ivan N
description Photodynamic therapy (PDT) has been successfully applied in clinical settings to destroy neoplasms, but the efficacy of such a treatment is dependent on the type of neoplasm and the photosynthesizer used. Here, we perform a clinical assessment of PDT for skin metastases of pigmented melanoma using chlorin e(6). PDT with chlorin e(6) photosensitizer was administered to 14 patients with skin metastases from melanoma (10 females, four males, mean age 49.6 years). Chlorin e(6) at a dose of 5 mg/kg of patient's weight was intravenously injected. The treatment course consisted of two courses of PDT exposure 1 h after intravenous chlorin e(6) injection and 24 h post-injection. The light energy density for each skin tumor was 80-120 J/cm(2) per treatment, with a light power density of 250-300 mW/cm(2). All skin melanoma metastases that received PDT showed complete regression with no recurrence during the study period. The complete response of all skin metastases from melanoma occurred in eight cases after one PDT treatment. In the remaining six individuals, tumors required multiple PDT courses prior to complete regression. No cases of photodermatitis were registered. The Karnofsky performance scale score of the patients with skin metastases from melanoma showed no significant difference before and after PDT. No patients had significant changes in blood cell counts that would indicate chlorin e(6) systemic toxic effect. Blood chemistry and urinalysis did not show any evidence of chlorin e(6) renal and hepatic injury. PDT with chlorin e(6) for skin metastases from melanoma is effective and well tolerated. Further clinical investigation of PDT with chlorin e(6) is warranted.
doi_str_mv 10.1111/j.1600-0781.2004.00078.x
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_14738529</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14738529</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-a3c8c36ca4000bb108cd94d178188272bcc49072d0782bf7d3ad05ec63bff0653</originalsourceid><addsrcrecordid>eNo1j0tLxDAUhbNQnHH0L0iWumi8ebRNlzI4ozCgC10PedKObVOaiPbfG1AvB-75uHA5ByFMgdA89ydCK4ACakkJAxAEIHvyfYbW0EBZCC75Cl3GeMoHIYBeoBUVNZcla9Zo99qGFOwyqqEzOLVuVtOCv7rUYtP2Ye5G7G6rO-zDjONHpsElFbNcxMFn6tUYBnWFzr3qo7v-2xv0vnt82z4Vh5f98_bhUEyUN6lQ3EjDK6NEzqI1BWlsIyzN2aVkNdPGiAZqZnMDpn1tubJQOlNx7T1UJd-gm9-_06cenD1OczeoeTn-F-I_F9lM2w</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Photodynamic therapy with chlorin e(6) for skin metastases of melanoma</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Sheleg, Sergey V ; Zhavrid, Edvard A ; Khodina, Tatsiana V ; Kochubeev, Georgy A ; Istomin, Yury P ; Chalov, Vadim N ; Zhuravkin, Ivan N</creator><creatorcontrib>Sheleg, Sergey V ; Zhavrid, Edvard A ; Khodina, Tatsiana V ; Kochubeev, Georgy A ; Istomin, Yury P ; Chalov, Vadim N ; Zhuravkin, Ivan N</creatorcontrib><description>Photodynamic therapy (PDT) has been successfully applied in clinical settings to destroy neoplasms, but the efficacy of such a treatment is dependent on the type of neoplasm and the photosynthesizer used. Here, we perform a clinical assessment of PDT for skin metastases of pigmented melanoma using chlorin e(6). PDT with chlorin e(6) photosensitizer was administered to 14 patients with skin metastases from melanoma (10 females, four males, mean age 49.6 years). Chlorin e(6) at a dose of 5 mg/kg of patient's weight was intravenously injected. The treatment course consisted of two courses of PDT exposure 1 h after intravenous chlorin e(6) injection and 24 h post-injection. The light energy density for each skin tumor was 80-120 J/cm(2) per treatment, with a light power density of 250-300 mW/cm(2). All skin melanoma metastases that received PDT showed complete regression with no recurrence during the study period. The complete response of all skin metastases from melanoma occurred in eight cases after one PDT treatment. In the remaining six individuals, tumors required multiple PDT courses prior to complete regression. No cases of photodermatitis were registered. The Karnofsky performance scale score of the patients with skin metastases from melanoma showed no significant difference before and after PDT. No patients had significant changes in blood cell counts that would indicate chlorin e(6) systemic toxic effect. Blood chemistry and urinalysis did not show any evidence of chlorin e(6) renal and hepatic injury. PDT with chlorin e(6) for skin metastases from melanoma is effective and well tolerated. Further clinical investigation of PDT with chlorin e(6) is warranted.</description><identifier>ISSN: 0905-4383</identifier><identifier>DOI: 10.1111/j.1600-0781.2004.00078.x</identifier><identifier>PMID: 14738529</identifier><language>eng</language><publisher>England</publisher><subject>Female ; Humans ; Male ; Melanoma - drug therapy ; Melanoma - pathology ; Melanoma - secondary ; Middle Aged ; Photochemotherapy - adverse effects ; Porphyrins - adverse effects ; Porphyrins - therapeutic use ; Radiation-Sensitizing Agents - adverse effects ; Radiation-Sensitizing Agents - therapeutic use ; Skin Neoplasms - drug therapy ; Skin Neoplasms - pathology ; Skin Neoplasms - secondary</subject><ispartof>Photodermatology, photoimmunology &amp; photomedicine, 2004-02, Vol.20 (1), p.21</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14738529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sheleg, Sergey V</creatorcontrib><creatorcontrib>Zhavrid, Edvard A</creatorcontrib><creatorcontrib>Khodina, Tatsiana V</creatorcontrib><creatorcontrib>Kochubeev, Georgy A</creatorcontrib><creatorcontrib>Istomin, Yury P</creatorcontrib><creatorcontrib>Chalov, Vadim N</creatorcontrib><creatorcontrib>Zhuravkin, Ivan N</creatorcontrib><title>Photodynamic therapy with chlorin e(6) for skin metastases of melanoma</title><title>Photodermatology, photoimmunology &amp; photomedicine</title><addtitle>Photodermatol Photoimmunol Photomed</addtitle><description>Photodynamic therapy (PDT) has been successfully applied in clinical settings to destroy neoplasms, but the efficacy of such a treatment is dependent on the type of neoplasm and the photosynthesizer used. Here, we perform a clinical assessment of PDT for skin metastases of pigmented melanoma using chlorin e(6). PDT with chlorin e(6) photosensitizer was administered to 14 patients with skin metastases from melanoma (10 females, four males, mean age 49.6 years). Chlorin e(6) at a dose of 5 mg/kg of patient's weight was intravenously injected. The treatment course consisted of two courses of PDT exposure 1 h after intravenous chlorin e(6) injection and 24 h post-injection. The light energy density for each skin tumor was 80-120 J/cm(2) per treatment, with a light power density of 250-300 mW/cm(2). All skin melanoma metastases that received PDT showed complete regression with no recurrence during the study period. The complete response of all skin metastases from melanoma occurred in eight cases after one PDT treatment. In the remaining six individuals, tumors required multiple PDT courses prior to complete regression. No cases of photodermatitis were registered. The Karnofsky performance scale score of the patients with skin metastases from melanoma showed no significant difference before and after PDT. No patients had significant changes in blood cell counts that would indicate chlorin e(6) systemic toxic effect. Blood chemistry and urinalysis did not show any evidence of chlorin e(6) renal and hepatic injury. PDT with chlorin e(6) for skin metastases from melanoma is effective and well tolerated. Further clinical investigation of PDT with chlorin e(6) is warranted.</description><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Melanoma - drug therapy</subject><subject>Melanoma - pathology</subject><subject>Melanoma - secondary</subject><subject>Middle Aged</subject><subject>Photochemotherapy - adverse effects</subject><subject>Porphyrins - adverse effects</subject><subject>Porphyrins - therapeutic use</subject><subject>Radiation-Sensitizing Agents - adverse effects</subject><subject>Radiation-Sensitizing Agents - therapeutic use</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Skin Neoplasms - pathology</subject><subject>Skin Neoplasms - secondary</subject><issn>0905-4383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0tLxDAUhbNQnHH0L0iWumi8ebRNlzI4ozCgC10PedKObVOaiPbfG1AvB-75uHA5ByFMgdA89ydCK4ACakkJAxAEIHvyfYbW0EBZCC75Cl3GeMoHIYBeoBUVNZcla9Zo99qGFOwyqqEzOLVuVtOCv7rUYtP2Ye5G7G6rO-zDjONHpsElFbNcxMFn6tUYBnWFzr3qo7v-2xv0vnt82z4Vh5f98_bhUEyUN6lQ3EjDK6NEzqI1BWlsIyzN2aVkNdPGiAZqZnMDpn1tubJQOlNx7T1UJd-gm9-_06cenD1OczeoeTn-F-I_F9lM2w</recordid><startdate>200402</startdate><enddate>200402</enddate><creator>Sheleg, Sergey V</creator><creator>Zhavrid, Edvard A</creator><creator>Khodina, Tatsiana V</creator><creator>Kochubeev, Georgy A</creator><creator>Istomin, Yury P</creator><creator>Chalov, Vadim N</creator><creator>Zhuravkin, Ivan N</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200402</creationdate><title>Photodynamic therapy with chlorin e(6) for skin metastases of melanoma</title><author>Sheleg, Sergey V ; Zhavrid, Edvard A ; Khodina, Tatsiana V ; Kochubeev, Georgy A ; Istomin, Yury P ; Chalov, Vadim N ; Zhuravkin, Ivan N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-a3c8c36ca4000bb108cd94d178188272bcc49072d0782bf7d3ad05ec63bff0653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Melanoma - drug therapy</topic><topic>Melanoma - pathology</topic><topic>Melanoma - secondary</topic><topic>Middle Aged</topic><topic>Photochemotherapy - adverse effects</topic><topic>Porphyrins - adverse effects</topic><topic>Porphyrins - therapeutic use</topic><topic>Radiation-Sensitizing Agents - adverse effects</topic><topic>Radiation-Sensitizing Agents - therapeutic use</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Skin Neoplasms - pathology</topic><topic>Skin Neoplasms - secondary</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sheleg, Sergey V</creatorcontrib><creatorcontrib>Zhavrid, Edvard A</creatorcontrib><creatorcontrib>Khodina, Tatsiana V</creatorcontrib><creatorcontrib>Kochubeev, Georgy A</creatorcontrib><creatorcontrib>Istomin, Yury P</creatorcontrib><creatorcontrib>Chalov, Vadim N</creatorcontrib><creatorcontrib>Zhuravkin, Ivan N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Photodermatology, photoimmunology &amp; photomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheleg, Sergey V</au><au>Zhavrid, Edvard A</au><au>Khodina, Tatsiana V</au><au>Kochubeev, Georgy A</au><au>Istomin, Yury P</au><au>Chalov, Vadim N</au><au>Zhuravkin, Ivan N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Photodynamic therapy with chlorin e(6) for skin metastases of melanoma</atitle><jtitle>Photodermatology, photoimmunology &amp; photomedicine</jtitle><addtitle>Photodermatol Photoimmunol Photomed</addtitle><date>2004-02</date><risdate>2004</risdate><volume>20</volume><issue>1</issue><spage>21</spage><pages>21-</pages><issn>0905-4383</issn><abstract>Photodynamic therapy (PDT) has been successfully applied in clinical settings to destroy neoplasms, but the efficacy of such a treatment is dependent on the type of neoplasm and the photosynthesizer used. Here, we perform a clinical assessment of PDT for skin metastases of pigmented melanoma using chlorin e(6). PDT with chlorin e(6) photosensitizer was administered to 14 patients with skin metastases from melanoma (10 females, four males, mean age 49.6 years). Chlorin e(6) at a dose of 5 mg/kg of patient's weight was intravenously injected. The treatment course consisted of two courses of PDT exposure 1 h after intravenous chlorin e(6) injection and 24 h post-injection. The light energy density for each skin tumor was 80-120 J/cm(2) per treatment, with a light power density of 250-300 mW/cm(2). All skin melanoma metastases that received PDT showed complete regression with no recurrence during the study period. The complete response of all skin metastases from melanoma occurred in eight cases after one PDT treatment. In the remaining six individuals, tumors required multiple PDT courses prior to complete regression. No cases of photodermatitis were registered. The Karnofsky performance scale score of the patients with skin metastases from melanoma showed no significant difference before and after PDT. No patients had significant changes in blood cell counts that would indicate chlorin e(6) systemic toxic effect. Blood chemistry and urinalysis did not show any evidence of chlorin e(6) renal and hepatic injury. PDT with chlorin e(6) for skin metastases from melanoma is effective and well tolerated. Further clinical investigation of PDT with chlorin e(6) is warranted.</abstract><cop>England</cop><pmid>14738529</pmid><doi>10.1111/j.1600-0781.2004.00078.x</doi></addata></record>
fulltext fulltext
identifier ISSN: 0905-4383
ispartof Photodermatology, photoimmunology & photomedicine, 2004-02, Vol.20 (1), p.21
issn 0905-4383
language eng
recordid cdi_pubmed_primary_14738529
source MEDLINE; Access via Wiley Online Library
subjects Female
Humans
Male
Melanoma - drug therapy
Melanoma - pathology
Melanoma - secondary
Middle Aged
Photochemotherapy - adverse effects
Porphyrins - adverse effects
Porphyrins - therapeutic use
Radiation-Sensitizing Agents - adverse effects
Radiation-Sensitizing Agents - therapeutic use
Skin Neoplasms - drug therapy
Skin Neoplasms - pathology
Skin Neoplasms - secondary
title Photodynamic therapy with chlorin e(6) for skin metastases of melanoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A55%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Photodynamic%20therapy%20with%20chlorin%20e(6)%20for%20skin%20metastases%20of%20melanoma&rft.jtitle=Photodermatology,%20photoimmunology%20&%20photomedicine&rft.au=Sheleg,%20Sergey%20V&rft.date=2004-02&rft.volume=20&rft.issue=1&rft.spage=21&rft.pages=21-&rft.issn=0905-4383&rft_id=info:doi/10.1111/j.1600-0781.2004.00078.x&rft_dat=%3Cpubmed%3E14738529%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/14738529&rfr_iscdi=true